Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Cancer Discovery
Donna R RiveraCOVID-19 and Cancer Consortium

Abstract

Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer status, baseline COVID-19 severity) was performed. Hydroxychloroquine with any other drug was associated with increased mortality versus treatment with any COVID-19 treatment other than hydroxychloroquine or untreated controls; this association was not present with hydroxychloroquine alone. Remdesivir had numerically reduced mortality versus untreated controls that did not reach statistical significance. Baseline COVID-19 severity was strongly associated with receipt of any treatment. Black patients were approximately half as likely to receive remdesivir as white patients. Although observational studies can be limited by potential unmeasured confounding, our findings add to the emerging understanding of patterns of care for patients with cancer and COVID-19 and support evaluation of emerging treatments through inclusive prospective controlled trials. SIGNIFICANCE: Evaluating the potential role of COVID-19 treatments in patients with cancer in a...Continue Reading

References

Jun 4, 1999·American Journal of Epidemiology·M SalasB H Stricker
Mar 19, 2011·BMC Bioinformatics·Xavier RobinMarkus Müller
May 21, 2014·Antimicrobial Agents and Chemotherapy·Julie DyallMatthew B Frieman
Sep 12, 2015·IEEE Transactions on Visualization and Computer Graphics·Alexander LexHanspeter Pfister
Mar 30, 2018·Frontiers in Immunology·Petra ZimmermannNicole Ritz
May 18, 2019·American Society of Clinical Oncology Educational Book·Ryan D NippElectra D Paskett
Feb 14, 2020·The New England Journal of Medicine·Rory CollinsRichard Peto
Feb 19, 2020·The Lancet Oncology·Wenhua LiangJianxing He
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 25, 2020·International Journal of Antimicrobial Agents·Philippe GautretDidier Raoult
Apr 11, 2020·The New England Journal of Medicine·Jonathan GreinTimothy Flanigan
Apr 16, 2020·JAMA : the Journal of the American Medical Association·Clyde W Yancy
Apr 23, 2020·JAMA : the Journal of the American Medical Association·Safiya RichardsonTheodoros P Zanos
Apr 30, 2020·Nature Cancer·Aakash DesaiGilberto Lopes
May 2, 2020·The New England Journal of Medicine·Mandeep R MehraAmit N Patel
May 7, 2020·The New England Journal of Medicine·Merlin Chowkwanyun, Adolph L Reed
May 10, 2020·Journal of Epidemiology and Community Health·Saman Khalatbari-SoltaniMichelle Kelly-Irving
May 28, 2020·The New England Journal of Medicine·Eboni G Price-HaywoodLeonardo Seoane
May 28, 2020·The New England Journal of Medicine·Jason D GoldmanUNKNOWN GS-US-540-5773 Investigators
Jun 1, 2020·Lancet·Nicole M KudererUNKNOWN COVID-19 and Cancer Consortium
Jun 10, 2020·Journal of the American Society of Nephrology : JASN·Meagan L AdamsickMeghan E Sise
Jun 17, 2020·The Lancet Oncology·Marina Chiara GarassinoUNKNOWN TERAVOLT investigators
Jul 9, 2020·Nature·Elizabeth J WilliamsonBen Goldacre
Aug 25, 2020·The Lancet Rheumatology·Giovanni GuaraldiCristina Mussini
May 8, 2020·MedRxiv : the Preprint Server for Health Sciences·G. GriffithGibran Hemani

❮ Previous
Next ❯

Citations

Sep 19, 2020·Cancer Investigation·Nicole M Kuderer, Gary H Lyman
Aug 24, 2020·World Journal of Surgical Oncology·Mainak Chakraborty, Manoj Pandey
Oct 23, 2020·Cancer Investigation·Gary H Lyman, Nicole M Kuderer
Dec 2, 2020·Cancers·Mateus Bringel Oliveira DuarteJosé Barreto Campello Carvalheira
Dec 11, 2020·JAMA Oncology·Yu ShyrChih-Yuan Hsu
Nov 28, 2020·British Journal of Clinical Pharmacology·Juan PimentelNeil Andersson
Dec 8, 2020·International Journal of Cancer. Journal International Du Cancer·Nuriye ÖzdemirMutlu Hayran
Nov 12, 2020·Cancer Cell·UNKNOWN COVID-19 and Cancer Consortium. Electronic address: jeremy.warner@vumc.org, UNKNOWN COVID-19 and Cancer Consortium
Feb 4, 2021·Cancer Investigation·Nicole M KudererGary H Lyman
Dec 30, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jia-Tao ZhangYi-Long Wu
Feb 13, 2021·Transplantation Proceedings·Anna HardestyDimitrios Farmakiotis
Dec 24, 2020·Cancer Discovery·Antoni RibasUNKNOWN AACR COVID-19 and Cancer Task Force
Feb 16, 2021·Journal of the National Medical Association·Edith Peterson Mitchell
Mar 3, 2021·Scientific Reports·Justin JeeAnthony F Daniyan
Mar 1, 2021·Journal of Hematology & Oncology·Joyce K HwangZihai Li
Mar 7, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicola GiesenUNKNOWN COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical
Mar 12, 2021·JAMA Network Open·Antoine EskanderRinku Sutradhar
Mar 16, 2021·Cancer Investigation·Michael J WagnerElizabeth T Loggers
Mar 23, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P GrivasGdL Lopes
Aug 30, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Thibault FioletYahya Mahamat-Saleh
Apr 25, 2021·Cancer Cell·Christopher R FrieseJeremy L Warner
Apr 16, 2021·The Oncologist·Isaac A KleinAnn H Partridge
Nov 2, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Nicolas VedrinesAlexis Lacout
Jun 3, 2021·International Journal of Environmental Research and Public Health·Michelle S WongDonna L Washington
Jul 10, 2021·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Guisado-VascoJ M Jimeno
Jul 15, 2021·Journal of Thrombosis and Haemostasis : JTH·Ang LiUNKNOWN CCC19 consortium
Jun 18, 2021·JAMA Oncology·Michael A ThompsonUNKNOWN COVID-19 and Cancer Consortium
Aug 17, 2021·SN Comprehensive Clinical Medicine·Jun TaoPhilip A Chan
Sep 3, 2021·JAMA Oncology·Aakash DesaiMichael A Thompson
Aug 29, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Andrea SpiniLuigia Trabace
Oct 13, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Mario Jorge Sobreira da SilvaAnnemeri Livinalli
Aug 29, 2021·Journal of the National Cancer Institute·Astha ThakkarJeremy L Warner

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04321616
NCT04381936
NCT04356937
NCT04372186
NCT04370834
NCT04354701

Software Mentioned

REDCap
UpSetR
MatchIt
horseshoe
Hmisc
mediation
glmnet
R
rms
UpSet

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

European Journal of Internal Medicine
Silvano GallusAlessandra Lugo
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Peter E Wu, Andrew M Morris
© 2021 Meta ULC. All rights reserved